We are very pleased to inform that Genovax have been selected to present at the Healthcare Biotech Forum on March 30 & 31 in Rome, Italy. This will be the first public event where Genovax projects and future plans will be disclosed to a selected group of private investors. Genovax will illustrate not only the status of its present portfolio of projects - GX101 and GX 301 - but also preliminary findings on two new projects - GX 201 for immunotherapy and GX 401 for atherosclerosis - which are looking for financial support. More news on the Rome event are in http://www.e-unlimited.com/events/p200292/overview.asp

January 2009